More breast cancer patients could benefit from treatments currently used only for patients with a faulty BRCA1 or BRCA2 gene, an international research collaboration has shown.
14 March 2017More breast cancer patients could benefit from treatments currently used only for patients with a faulty BRCA1 or BRCA2 gene, an international research collaboration has shown.
14 March 2017